Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 13Gastrointestinal 8Tumor-Agnostic 3Thoracic 3Other hematologic neoplasm 3Head & Neck 3Lymphoid 2Sarcoma 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Lymphoma 1Leukemia 1Brain Neoplasms 1Attention Deficit Disorder with Hyperactivity 1

Interventions

Temozolomide 66Radiotherapy 52Carboplatin 25Bevacizumab 21Cisplatin 19Radiosurgery 18Vincristine 17Etoposide 17Cyclophosphamide 17Surgical Procedures, Operative 13Magnetic Resonance Spectroscopy 13Chemotherapy, Adjuvant 11Melphalan 10Lomustine 10Drug Therapy 10Filgrastim 9Erlotinib Hydrochloride 9apatinib 8Pemetrexed 83-Iodobenzylguanidine 8anlotinib 7Radiation 7Peripheral Blood Stem Cell Transplantation 7Methotrexate 7Thiotepa 6Isotretinoin 6Irinotecan 6Ifosfamide 6Doxorubicin 6Carmustine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Control Groups × CNS × Clear all
NCT00498719 2020-12-31

Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer

M.D. Anderson Cancer Center

Unknown
30 enrolled
CNSLymphoidOther hematologic neoplasm

Attention Deficit Disorder with Hyperactivity, Brain Neoplasms, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡